Ultraselective transcatheter arterial chemoembolization with a 2-F tip microcatheter for small hepatocellular carcinomas: Relationship between local tumor recurrence and visualization of the portal vein with iodized oil

被引:252
作者
Miyayama, Shiro
Matsui, Osamu
Yamashiro, Masashi
Ryu, Yasuji
Kaito, Keiko
Ozaki, Kumi
Takeda, Taro
Yoneda, Norihide
Notsumata, Kazuo
Toya, Daisyu
Tanaka, Nobuyoshi
Mitsui, Takeshi
机构
[1] Fukuiken Saiseikai Hosp, Dept Diagnost Radiol, Fukui 9188503, Japan
[2] Fukuiken Saiseikai Hosp, Dept Internal Med, Fukui 9188503, Japan
[3] Fukuiken Saiseikai Hosp, Dept Surg, Fukui 9188503, Japan
[4] Kanazawa Univ, Grad Sch Med Sci, Dept Radiol, Kanazawa, Ishikawa 9208640, Japan
关键词
D O I
10.1016/j.jvir.2006.12.004
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 [临床医学]; 100207 [影像医学与核医学]; 1009 [特种医学];
摘要
PURPOSE: To retrospectively evaluate the relationship between local tumor recurrence and iodized oil deposition in the portal vein by using ultraselective transcatheter arterial chemoembolization (TACE) for small hepatocellular carcinoma. MATERIALS AND METHODS: One-hundred twenty-three tumors smaller than 5 cm in diameter (mean diameter, 1.9 cm; median diameter, 1.6 cm) were treated with TACE by using a 2-F tip microcatheter at a distal portion of the subsegmental artery of the liver. Portal vein visualization at spot radiography during TACE was divided into three grades, as follows: 0 = not visualized, 1 = limited near the tumor, and 2 = whole or extended to the embolized area. Local recurrence rates of each grade group were compared. The recurrent pattern was divided into intratumoral and peritumoral recurrence. Complications were also analyzed. RESULTS: Of the 123 tumors, 53 (43.1%) were classified as grade 2, 52 (42.3%) were classified as grade 1, and 18 (14.6%) tumors were classified as grade 0. Overall local recurrence rates at 12, 24, and 36 months were 25.6%, 34.7%, and 34.7%, respectively. The local recurrence rates for the grades 2, 1, and 0 groups were 7.9%, 24.8%, and 85.7%, respectively, at 12 months and 17.7%, 38.9%, and 85.7% at 24 months. Recurrence rates in the grade 2 group were significantly lower than those in the grades 1 and 0 groups (P =.0485 and P <.0001, respectively). Intratumoral recurrence was observed in 21 tumors, most of which were in the grade 0 group. Peritumoral recurrence was noted in 16 tumors, most of which were in the grade 2 group. There were no major complications. CONCLUSION: Ultraselective TACE was safe and effective in a significant number of tumors. In particular, local recurrence was significantly lower when a greater degree of portal vein visualization was demonstrated during TACE.
引用
收藏
页码:365 / 376
页数:12
相关论文
共 27 条
[1]
Quality improvement guidelines for transhepatic arterial chemoembolization, embolization, and chemotherapeutic infusion for hepatic malignancy [J].
Brown, DB ;
Cardella, JF ;
Sacks, D ;
Goldberg, SN ;
Gervais, DA ;
Rajan, D ;
Vedantham, S ;
Miller, DL ;
Brountzos, EN ;
Grassi, CJ ;
Towbin, RB .
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2006, 17 (02) :225-232
[2]
Hepatocellular carcinoma supplied by portal flow after repeated transcatheter arterial chemoembolization [J].
Choi, SH ;
Chung, JW ;
Lee, HS .
AMERICAN JOURNAL OF ROENTGENOLOGY, 2003, 181 (03) :889-890
[3]
BLOOD-SUPPLY OF EXPERIMENTAL LIVER-TUMORS AFTER INTRAARTERIAL EMBOLIZATION WITH GELFOAM POWDER AND ABSOLUTE ETHANOL [J].
EKELUND, L ;
LIN, G ;
JEPPSSON, B .
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 1984, 7 (05) :234-239
[4]
GOSEKI N, 1995, CANCER, V76, P736, DOI 10.1002/1097-0142(19950901)76:5<736::AID-CNCR2820760505>3.0.CO
[5]
2-Q
[6]
Correlation between the blood supply and grade of malignancy of hepatocellular modules associated with liver cirrhosis: Evaluation by CT during intraarterial injection of contrast medium [J].
Hayashi, M ;
Matsui, O ;
Ueda, K ;
Kawamori, Y ;
Kadoya, M ;
Yoshikawa, J ;
Gabata, T ;
Takashima, I ;
Nonomura, A ;
Nakamura, Y .
AMERICAN JOURNAL OF ROENTGENOLOGY, 1999, 172 (04) :969-976
[7]
Higashihara H, 2002, HEPATO-GASTROENTEROL, V49, P72
[8]
Use of a combined CT-angiography system for demonstration of correlative anatomy during embolotherapy for hepatocellular carcinoma [J].
Ishijima, H ;
Koyama, Y ;
Aoki, J ;
Kawano, T ;
Nakajima, T ;
Ishizaka, H ;
Endo, K .
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 1999, 10 (06) :811-815
[9]
Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma [J].
Llovet, JM ;
Vilana, R ;
Brú, C ;
Bianchi, L ;
Salmeron, JM ;
Boix, L ;
Ganau, S ;
Sala, M ;
Pagès, M ;
Ayuso, C ;
Solé, M ;
Rodés, J ;
Bruix, R .
HEPATOLOGY, 2001, 33 (05) :1124-1129
[10]
SMALL HEPATOCELLULAR-CARCINOMA - TREATMENT WITH SUBSEGMENTAL TRANSCATHETER ARTERIAL EMBOLIZATION [J].
MATSUI, O ;
KADOYA, M ;
YOSHIKAWA, J ;
GABATA, T ;
ARAI, K ;
DEMACHI, H ;
MIYAYAMA, S ;
TAKASHIMA, T ;
UNOURA, M ;
KOGAYASHI, K .
RADIOLOGY, 1993, 188 (01) :79-83